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Although the proximal, 5' 115 bp of the human carbonic anhydrase II (CA II) 
gene was sufficient for expression of a reporter gene in some transfected cell lines, 
we found previously that 1100 bp of this promoter (or 500 bp of the mouse CA II 
promoter) was not sufficient for expression in transgenic mice. We have now 
studied the expression of linked reporter genes in mice transgenic for either (1) l 1 
kb of the human 5' promoter or (2) 8 kb of the human 5' promoter with mouse 
sequences from the first exon, part of the first intron (since a CpG island spans 
this region), and the 3' sequences of the gene. Expression was found in both 
cases, but the tissue specificity was not appropriate for CA II. Although there was 
a difference in the sensitivity of the assays used, the frst  construct led to 
expression in many tissues, while the second construct was expressed only in 
spleen. These findings indicate considerable complexity of DNA control regions 
for in v ivo  CA II expression. 
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INTRODUCTION 
Carbonic anhydrase (CA) catalyzes the reversible hydration of carbon 
dioxide. Nine CA or CA-like isozymes have so far been described in the 
multigene family (Tashian, 1989, 1992; Pastorek et aL, 1994), of which CA II 
provides the most enzymatic activity. The human and mouse CA II genes 
have been cloned and sequenced (Venta et al., 1985a,b, 1991). In mice, the 
CA I, CA II, and CA III genes are tightly linked in the centromerie region of 
chromosome 3 (Eicher et aL, 1976; Beeehey et aL, 1989), and in man these 
three genes are closely linked on the long arm of chromosome 8 (Davis et al., 
1987; Nakai et aL, 1987; Lowe et aL, 1991). An interesting feature of the CA 
II gene in mammals is that it is expressed in almost all tissues, but only in a 
limited subset of cells (Tashian et aL, 1984). Thus a variety of controlling 
elements may be expected to participate in the mechanism of regulation of 
CA II expression. In addition, CA II is inducible by 1,25-dihydroxy vitamin 
D3 in HL60 cells (Shapiro et aL, 1989) as they differentiate into osteoclasts. 
Thus, increased understanding of this promoter is relevant to osteoclast 
function and the osteoporosis of aging. CA II is also androgen inducible--an 
induction studied in the rat lateral prostate, where CA II makes up 15% of 
the soluble protein (Harkonen and Vaananen, 1988). 
The nucleotide sequences surrounding the first and second exons of the 
human and mouse CA II genes have been compared (Venta et al., 1985a), 
with an overall percentage identity of 81% and an even higher identity of 
88% in the first exon. The region surrounding the TATA box is moderately 
conserved (60%, -243 to TATA; 69%, TATA to ATG). The regions 
700-800 bp on either side of the first exon are extremely G and C rich. Such 
islands have been shown to be associated with the 5' regions of many 
mammalian genes. About 90% of methylated cytosines in mammalian DNA 
are found in the CpG sequence. This methylation is implicated in the control 
of gene expression in higher eukaryocytes. 
An important step in understanding gene function is the elucidation of 
a gene's control elements. Transfection of cultured cells is an important first 
step but the results are frequently misleading, e.g., collagen promoters 
(Krebsbach et aL, 1993) and HSP70.1 (Thompson et al., 1994). This is 
certainly true of CA II. Calcium phosphate-mediated transfection of long- 
established cell lines showed that as few as 115 bp (mouse Ltk- fibroblasts) 
or 200 bp (human HeLa cells) of 5' promoter region led to abundant 
expression of the reporter gene (Shapiro et al., 1987). A finer analysis of this 
promoter in NIH-3T3 and HepG2 cells, also using CaPO4 transfection, 
confirmed the effectiveness of short segments (down to 90 bp) in promoting 
transcription (Marino, 1993). A more recent study of the CA II promoter in 
renal cells and using lipofection showed that 1.1 kb of proximal 5' sequence 
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was optimal (Lai et aL, 1995). As a control, lipofection was used as the mode 
of transfection for HeLa ceils, and 1.1 kb was optimal in HeLa cells with this 
mode of delivery (Lai et al., 1995). Importantly, the latter results employed a 
control for transfection efficiency which was not employed in the other two 
studies. 
It has frequently been found that the control elements needed for 
proper in vivo regulation are different than those needed in vitro. Thus, it is 
not surprising that even 1.1 kb of proximal 5' sequences did not result in any 
expression in transgenic mice (Erickson et al., 1990). We have now studied 
mice transgenic for constructs containing much larger amounts of 5' se- 
quence with or without the gene sequences needed to include all of the CA 
II, 5' CpG island (Venta et aL, 1985a) and 3', potential regulatory sequences 
in order to determine if these sequences would lead to the normal pattern of 
expression. Abundant expression, but not in an appropriate pattern, was 
found. 
MATERIALS AND METHODS 
Constructs 
pHCAIICAT-12 kb. This construct (Fig. 1) contains nearly 12 kb from the 
flanking region of the human CA II (Venta et aL, 1991) gene fused to the 
chloramphenicol acetyltransferase gene derived from pSV2CAT (Gorman 
et al., 1982). The parent plasmid to pHCAIICAT-12kb was the pHCAIICAT- 
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Fig. 1. Schematic diagram of pHCAIICAT-12 kb. The box shows the location of the 
chloramphenicol acetyltransferase (CAT) gene. The arrowheads show the regions 
derived from the 5' region of the human carbonic anhydrase II gene and the pSV2CAT 
plasmid. The "x" indicates the region of the T t h l l l I  site that was destroyed during the 
cloning procedure. This T t h l l l I  site directly overlies the CA II translation start codon in 
the CA-2 gene. The gene construct could be conveniently removed from the vector (not 
shown) by digesting the DNA with StuI and BamHI.  See Methods and Materials for a 
more detailed description of the generation of this construct. 
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1400 plasmid previously described (Shapiro et aL, 1987). Briefly, pHCAII- 
CAT-1400 was derived by end-filling the HindlII  site of pSV2CAT and the 
Tth111I site of H25-3.8 (which contains the first exon and promoter region of 
the human CA-2 gene) followed by blunt-end ligation (Shapiro et al., 1987). 
The Tth111I site directly overlies the initiation codon for CA II protein 
(Venta et al., 1985a) and the HindlII  site is 35 bp upstream of the start of 
translation of the CAT protein (Gorman et aL, 1982; Genbank Accession 
No. G77788). pHCAIICAT-1400 contains 1288 nucleotides (originally esti- 
mated as 1400 bp by gel electrophoresis) upstream of the start of transcrip- 
tion of the human CA-2 gene (Venta et aL, 1991). Fusion of an additional 10 
kb of 5' flanking region to the parent plasmid was accomplished as follows: 
pHCAIICAT-1400 was digested with both StuI and SaclI. This removed the 
enhancer-promoter region of SV40 originally contained in the parent 
plasmid as well as about 1 kb of the CA-2 promoter region (which was 
subsequently returned in the next step). In a separate reaction, 11 kb of 5' 
flanking region of the human CA-2 gene was removed from the lambda 
bacteriophage clone H25 (Venta et al., 1991) by digestion with StuI and 
SaclI. These two fragments were ligated to produce pHCAIICAT-12kb. The 
correct order and size of the restriction fragments contained within the 
clone (Fig. 1) were confirmed by appropriate restriction enzyme digestions. 
pMHCAII-8 kb. This construct (Fig. 2) contains about 8 kb of 5' 
flanking region from the human CA-2 gene fused to 378 bp of the mouse 
Car-2 promoter [counting to the putative transcription start site (Venta et 
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Fig. 2. Schematic diagram of pMHCAII-8 kb. The boxes show the location of the two 
exons of the construct. The white areas of the boxes indicate the untranslated regions, 
whereas the black areas indicate the protein-coding regions. The first exon is derived 
from the mouse carbonic anhydrase II gene and the second exon is a minigene 
construct derived from the human carbonic anhydrase II gene and its cDNA. The 
arrowheads at the bottom show the locations of human- and mouse-derived se- 
quences. The # sign shows the location of the EcoRI  site that was destroyed and 
replaced by anXhol site by ligation of an XhoI linker. The four "x's" show the location 
of the missing BamHI  and BglII sites that were ligated by their complementary ends to 
fuse the human and mouse sequences at these points [see Curtis et al. (1983) and 
Venta et al. (1985a,b) for exact sequences]. The gene construct could be conveniently 
removed from the plasmid vector (not shown in this figure) by digesting the DNA with 
SalI and XhoI. See Methods and Materials for a more detailed description of the 
generation of this construct. 
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al., 1985a)]. It uses human CA II as the reporter gene to eliminate all 
prokaryote sequences and uses mouse sequences where possible (although 
mouse human sequence differences have generally been irrelevant; see 
Discussion). The fusion between these two regions is at a SacII site which 
occurs in a nearly identical position in both the human and the mouse genes 
[(Venta et al., 1985a) from the transcription start site, -356 for the human 
and -378 for the mouse]. The two parent plasmids involved in the construc- 
tion of pMHCAII-8kb are pMHCAII (described next) and pHCAIICAT-12 
kb (described above). Briefly, pMHCAII was constructed from pBS- and 
four DNA fragments (in their order in the clone): the 1.9-kb BamHI-BglII  
piece from A6-2.7 (Venta et al., 1985b), the 0.6-kb BamHI-BarnHI  piece 
from H25-3.8 (Venta et al., 1991), the 0.7-kb BarnHI-BgIII piece from 
pHCAI138.3 (Montgomery et al., 1987), and the 1.7-kb B a m H I - E c o R I  piece 
from A6-3.5 (Venta et al., 1985b). These fragments were ligated in the 
appropriate order to produce pMHCAII. The EcoRI  site in pMHCAII was 
cut and end-filled using standard procedures (Maniatis et al., 1982) and this 
was followed by the addition of XhoI linkers. Cohesive ends were generated 
by digestion of the ligated XhoI linkers and the plasmid was recircularized by 
ligation. This plasmid was cut at the SacI1 site and SalI site [contained in the 
polylinker of the pBSM13-vector (Stratagene, San Diego)]. The plasmid was 
gel purified away from the small "linker" piece. In a separate reaction, the 
SalI-SacII fragment of pHCAIICAT-12 kb was isolated by a similar proce- 
dure. These two DNA pieces were ligated to produce pMHCAII-8kb. 
Appropriate restriction digestions were performed (Fig. 2) to confirm the 
identity of the plasmid. The protein produced from this construct should be 
identical to the human CA II except for a single conservative and non-charge- 
changing amino acid substitution of serine for glycine at amino acid position 
7. Thus, the product of the transgene and the endogenous mouse CA II are 
electrophoretically distinguishable due to the charge differences between 
the human and the mouse CA II isozymes. 
Transgenics 
The fragments described above were excised, purified by Schleicher and 
Shuell Elutip, and suspended in 10 mM Tris, 0.25 mM EDTA for injection. 
Injection was performed by the National Transgenic Development Facility 
into C57BL/6J x SJL/J F2 zygotes by standard techniques (F1 parents are 
used to avoid the two-cell block to development). Positive transgenics were 
identified by the polymerase chain reaction (PCR). In the case of 
pHCAIICAT-12 kb, a reaction buffer (Promega--Madison) containing 50 
mM KCI, 10 mM Tris-HC1, pH 9.0, 1.5 mM MgC12, 0.1% gelatin (w/v), 1% 
Triton X-100, 100 txmol of each dNTP, and a 0.5 ~xM concentration of each 
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primer per 50 ~l of reaction mixture was covered with light mineral oil and 
2.5 U of Taq polymerase (Promega-Madison) was added. Genomic mouse 
DNA (50-100 ng) was added to the reaction mixture at a temperature above 
the annealing temperature. The samples were amplified for 30 cycles 
consisting of denaturation at 95°C for 1.3 rain, annealing at 55°C for 1.3 min, 
and extension at 72°C for 1.3 rain, with a final extension at 72°C for 10 rain on 
the 30th cycle. The 5' primer is located at 335-365 bp (designation of 
Ohtsubo and Ohtsubo, 1978) in the CAT sequence (5'CCA GAC CGT TCA 
GCT GGA TAT TAC GGC CTT 3') and the 3' primer is located at 542-568 
bp in the CAT sequence (5' AGT GAA TAC CAC GAC GAT TTC CGG 
CAG 3'). The primers bracket a target sequence 233 bp in length. A 9-~1 
aliquot was electrophoresed on a 4% Nusieve agarose-Tris-acetate-EDTA 
gel. To detect the pMHCAII-8 kb transgene, primers were made at sites 
with significant variation between human and mouse CA II. The primers 
were 5' GAGGTTCTCAGACCTGTTAT 3' and 5' GTAAAGCTCTTAG- 
ATCACTG 3', which generate a 295-bp product. The conditions used were 
as described above but with 33 1.3-min cycles of 95, 53, and 72°C followed by 
9.9 min of extension at 72°C. 
Southern Analyses 
Ten micrograms of genomic DNA was digested overnight with 40 U of 
EcoRI, electrophoresed on a 0.9% agarose gel, and transferred by capillary 
action, using 10× SSC, to a nylon membrane after depurination in 0.25 N 
HC1 and denaturation in 0.5 N NaOH. The filter was hybridized with the 
32p-labeled 1800-bp NcoI-HindIII fragment of pSVOCAT. 
Cell Separations 
To prepare nucleated blood cells for analysis of CAT activity, two transgenic 
females were injected i.p. with 0.1 ml of a 1/5 dilution of India Ink in PBS to 
help localize lymph nodes. The animals were warmed and bled (the source 
of peripheral blood leukocytes; PBLs). They were then sacrificed and the 
thymi, mesenteric lymph nodes, and spleens dissected. These were teased 
apart in PBS (separately for tissue, pooled for the two animals). The tissue 
fragments were allowed to settle, the supernatants counted in a hemocytom- 
eter, and the suspensions adjusted to 106/ml of PBS, frozen, and assayed for 
CAT as described above. The heparinized blood was diluted 10-fold in cold, 
0.83% NHnCI to lyse RBCs and centrifuged at 500g for 5 min. The cell pellet 
was resuspended in NH4C1, then centrifuged, and the white pellet sus- 
pended at 106/ml in PBS, frozen, and assayed for CAT as described above. 
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Chloramphenicol Acetyl Transferase Assays 
CAT assays were performed essentially according to the previously de- 
scribed protocol (Gorman et al., 1982). Tissues were homogenized 1:1 (w/v) 
with 0.75 M Tris, pH 7.8. Insoluble debris was pelleted, the supernatant was 
heated to 60°C for 10 rain to inactivate endogenous acetylases, and coagu- 
lated proteins were pelleted. Fifty micrograms of soluble protein was 
incubated in the standard assay (Gorman et al., 1982) for 2 hr at 37°C, and 
the amount of radiolabeled acylated chloramphenicol was analyzed by 
thin-layer chromatography (TLC). The TLC plates were autoradiographed 
for 12-16 hr. In some cases, a CAT enzyme immunoassay was performed, 
using the CAT-ELISA c kit from Boehringer Mannheim and was used 
according to their instructions. This assay was found to be less sensitive and 
was used only to compare white blood cell activities. 
Electrophoreses and Histochemistry of CA II 
Tissue samples (0.1-0.2 g) were homogenized in 0.5 ml PBS, then centri- 
fuged, and the supernatant (up to 5 ~1) was applied to 57 x 140-mm Cellogel 
strips (Crescent Chemical, Hauppauge, NY). Electrophoresis was carried 
out at 300 V for 2.5-3 hr in 0.09 M Tris-HC1 buffer, pH 9.1, containing 2.8 
mM EDTA and 10 mM boric acid. Electrophoretically separated mouse and 
human CA isozymes were tested for CA activity by staining strips with 0.1 M 
Veronal buffer, pH 9.0, containing 0.15% bromthymol blue. Carbonic 
anhydrase activity (yellow spots) was visualized when stained strips were 
flooded with CO2 (Tashian, 1969). 
RESULTS 
pHCAIICAT-12 kb Construct 
Nine transgenic founders were identified, of which seven were fertile. 
Southern analyses after digestion with E c o R I  demonstrated lack of internal 
rearrangements and variable dosages of the construct in several lines 
(Fig. 3). Abundant expression was found in many tissues (Table I, Figs. 4 and 5). 
Although there was some variation in expression of the CAT reporter gene 
from line to line, e.g., sterile animal 1618 had relatively high basal brain and 
kidney expression and sterile founder 34 had high expression in stomach, 
most of the transgenic animals had a very similar pattern of reporter gene 
expression. Levels of expression were very high in spleen (normally a 
moderately expressing tissue) and testes (normally a high expressing tissue) 
but low in many tissues in which CA II is normally highly expressed: blood, 
kidney, and lung. Since imprinting of transgenes occurs frequently, we 
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Fig. 3. Southern analysis of genomic DNA from representative positive and negative 
pHCAIICAT-12 kb transgenics after digestion with EcoRI and hybridization to a probe 
from pSVOCAT. Lane 1, individual mouse from line 33, PCR positive; lane 2, 
individual mouse from line 33, PCR negative; lane 3, another line 33, PCR-positive 
mouse; lane 4, individual from line 36, PCR positive; lane 5, another line 36, PCR- 
positive mouse. 
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Table II. ELISA Determination of Chloramphenicol Acetyl Transferase (CAT) Recorder 
Gene Activity in Purified Cell Fractions 
Cells CAT (pg/10 6 cells) 
Splenocytes 844 -+ 125 a (3) 
Thymocytes 116 _+ 13.5 (3) 
Lymphocytes 100 
Peripheral blood leukocytes 19.5 
i 
aMean ___ SE (N). 
compared expression when the transgene was transmitted by males com- 
pared to females. The variation in expression was not correlated with the 
transmitting parent but was correlated with the different transgenic lines. 
Since the spleen is populated largely by B and T lymphocytes, we 
performed preliminary studies on transgene expression in cell fractions from 
appropriate tissues using the ELISA assay (Table II). Splenocytes showed 
much higher levels of CAT gene expression than did thymocytes (primarily 
T cells), lymphocytes from mesenteric lymph nodes (B and T lymphocytes), 
or peripheral blood leukocytes (granulocytes, monocytes, and B and T 
lymphocytes). These results suggest that T or B lymphocytes are not the 
major contributors to high expression in spleen. 
pMHCAII-8 kb Construct 
Two founders were identified, of which only one was fertile. The histochemi- 
cal technique was used, after electrophoresis to separate mouse from human 
CA II. This less sensitive (than CAT activity) assay detected expression of 
this reporter gene only in spleen (Fig. 6). This activity was readily detected 
in spleen extracts of the founder of one line and five animals of the other 
line, when the gene was transmitted both maternally and paternally. No 
expression was found in blood (4), heart (4), liver (6), lung (4), kidney (6), 
muscle (2), stomach (4), large intestine (1), testes (4), brain cortex (4), basal 
brain (1), and cerebellum (3) (the numbers in parentheses indicate the 
number of animals studied). This pattern of expression, given the lower 
sensitivity of the detection system, might be compatible with that seen in 
pHCAIICAT-12 kb except for the results in testes, which were similar to 
levels in spleen in most lines of pHCAIICAT-12 kb. 
DISCUSSION 
These results on regulation of CA II expression in transgenic mice provide a 
sharp contrast to the results found with transfections of cultured cells. 
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Fig. 6. Electrophoresis of human CA II (HCA II) and mouse CA II (MCA II) 
isozymes in spleen from mouse with pMHCAII-8 kb transgene. HCA II control 
(lane 1); normal heterozygous (Car-2a,b) mouse control (lane 2); mouse with 
HCA II transgene (lane 3); mouse with HCA II transgene + HCA II (lane 4). 
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Calcium phosphate-mediated transfections of relatively undifferentiated, 
long-term cultured cell lines indicated that only short stretches of 5' CA II 
sequences were needed for expression. For instance, when transfections of 
mouse Ltk- cells were studied, the addition of each GC box resulted in a 
stepwise increase in the ability of the human CA II promoter to direct 
transcription of the reporter gene (Shapiro et  al., 1987). The addition started 
at the TATA box and continued through each putative element until 
maximal levels were reached when all known elements up to position -300 
were included. Similarly, in human HeLa cells, transcription above back- 
ground was not seen until 149 bases of 5' sequence was included, when the 
reporter gene activity increased 10-fold, to nearly maximal levels (Shapiro et 
al., 1987). In contrast, lipofection studies of differentiated renal tubular cells 
indicated the role of other 5' sequences. Transcriptional activity up to 
10-fold above background levels was found with constructs containing 180 
and 270 bp of 5' sequence but an increase of up to 500-fold was induced by 
1.1 kb of 5' sequence (Lai et al., 1995). The high level of induction by the 
1.1-kb 5' sequence in both LLC-PK 1 ceils and mouse primary renal tubular 
cell cultures suggested that there is a regulatory element(s) located between 
-420 bp and -1.1 kb which is activated in renal tubular ceils. However, the 
same -1.1-kb construct was ineffective in transgenic mice (Erickson et  al., 
1990). 
We have now used 12 kb of 5' flanking CA II sequences in transgenic 
mice and find abundant expression in many tissues but not in the correct 
relative expression patterns. Testis, which is normally a high-expressing 
tissue for CA II, was consistently high for the reporter gene, while blood, 
which normally has the highest CA II activity of any tissue, was relatively low 
in reporter gene activity. Similarly, liver, which normally has low CA II 
enzymatic activity, was, in the transgenics, sometimes high, whereas lung 
and kidney, which are normally high CA II expressors, had low levels. 
Finally, spleen, which is not normally a highly expressing tissue for CA II, 
showed very high levels of reporter gene expression. The same 12-kb 
construct delivered by lipofection to cultured renal tubular cells provided no 
more effect than the 1.1-kb construct [or decreased expression if correction 
for number of copies is not performed (Lai et  al., 1995)]. 
The addition of that portion of the CpG island which is included in the 
first intron, and potential 3' regulatory sequences, but with only 8 kb 
(instead of 12 kb) of 5' sequences in pMHCAII-8 kb, did not further 
enhance specificity. In fact, expression (corresponding to high levels of 
expression given the sensitivity of the assay) was detected only in the spleen. 
Thus, the 4 kb of 5' sequences from -12  to - 8  kb may have enhancing 
activity which is not highly tissue specific. 
We have considered several reasons for the finding that the 12 kb of 
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flanking DNA allows the expression of the reporter gene but not in a 
manner analogous to endogenous CA II. The inappropriate high expression 
is not likely to be due to the insertion sites which can cause chromosomal 
position effects (A1-Shawi et al., 1990) since it was similar in a number of 
transgenic lines. Species specificity (since the 12 kb is human sequences) is 
unlikely to be involved--the chicken oL-actin (Petropoulos et al., 1989) and 
lysozyme (Bonifer et al., 1990) promoters work appropriately in transgenic 
mice. However, when there are species-specific patterns of gene expression, 
the promoter reflects its source, e.g., human Thy-1 retains a human pattern 
of expression in transgenic mice (Gordon et al., 1987). Locus control regions 
(LCR) are unlikely to be the explanation since the addition of LCRs to 
constructs requiring them raises low-level, gene dosage-independent expres- 
sion to high-level, dosage-dependent expression. These elements were first 
demonstrated for the human [3-globin locus, which required a distal regula- 
tory region located 50-60 kb upstream of the gene for high-level expression 
in transgenic mice (Grosveld et aL, 1987) or mouse erythroleukemia cells 
(Blom van Assendelft et al., 1989). The three CA genes, I, II, and III, are 
clustered (Lowe et al., 1991), as are the [3-globin loci but differ for tissue of 
expression rather than time of expression. Perhaps an LCR involved in the 
expression of such clustered, but diversely expressed, genes would show 
properties different from those of the [3-globin LCR. 
A major question is whether the missing regulatory region(s) is (are) 
within or outside the gene. Regulatory regions have been found in second 
introns [thymidine kinase (Rotheneder et al., 1991)] which we have not 
included. An alternative approach for finding the essential elements is 
suggested by recent success with YAC transgenesis (Schedl et al., 1993). 
Instead of adding further elements to our current constructs, if a YAC 
transgene can provide proper expression of CA II, subsequent transgenic 
constructs could delete portions to identify essential elements. 
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